Fulgent Genetics (FRA:7F0) Total Receivables: €65.5 Mil (As of Mar. 2026)


FRA:7F0 Fulgent Genetics Inc FRA:7F0
64 GF Score
Price €18.10
GF Value €20.87
! 4 Warning Signs
View Full Analysis

What is Fulgent Genetics Total Receivables?

Fulgent Genetics FRA:7F0 -0.55% 64 Total Receivables is €65.5 Mil as of Mar. 2026. GuruFocus rates FRA:7F0 with a GF Score™ of 64/100 and a GF Value™ of €20.87. The stock has 4 warning signs investors should review.

Fulgent Genetics's Total Receivables for the quarter that ended in Mar. 2026 was €65.5 Mil.

Fulgent Genetics Total Receivables Related Terms

Fulgent Genetics Total Receivables Historical Data

* Premium members only.

The historical data trend for Fulgent Genetics's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fulgent Genetics Total Receivables Chart

Fulgent Genetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 126.82 70.90 52.68 73.56 78.24

Fulgent Genetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.41 73.73 67.07 78.24 65.51
FRA:7F0
64GF Score
Fulgent Genetics Inc FRA:7F0
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fulgent Genetics Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €65.5 Mil mean?
Fulgent Genetics (FRA:7F0) has a Total Receivables of €65.5 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Fulgent Genetics and its competitors.
Is Fulgent Genetics' Total Receivables too high?
Fulgent Genetics' current Total Receivables is €65.5 Mil. Overall, Fulgent Genetics has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' Total Receivables compare to MYGN and CSTL?
Fulgent Genetics' Total Receivables of €65.5 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Diagnostics & Research company?
A good Total Receivables depends on the Medical Diagnostics & Research industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Fulgent Genetics and its competitors. Fulgent Genetics's current Total Receivables is €65.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Fulgent Genetics (FRA:7F0) has a current Total Receivables of €65.5 Mil. The stock's GF Value™ is €20.87, compared to a current price of €18.10 — trading 13.3% below its estimated fair value. The current Total Receivables is €65.5 Mil. Fulgent Genetics' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Fulgent Genetics (FRA:7F0), the current Total Receivables is €65.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fulgent Genetics (FRA:7F0) Overvalued in 2026?

Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued. The current stock price of €18.10 is trading 13.3% below its estimated GF Value™ of €20.87.

Key valuation signals for FRA:7F0:

  • Total Receivables: €65.5 Mil
  • GF Value™: €20.87 vs. price of €18.10 (13.3% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the FRA:7F0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fulgent Genetics Business Description

Other Exchanges FLGT:USAFLGT:Mexico
Address 4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
64GF Score

Get the complete analysis for FRA:7F0

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.10
Price
€20.87
GF Value